10.05.2024 15:00
Backed by the Bill and Melinda Gates Foundation, Axmed has secured additional $2 million to transform access to critical medicines in low- and middle-income countries. Its two-sided B2B marketplace bridges the gap between pharmaceutical manufacturers/suppliers and healthcare providers, ensuring a steady, affordable supply of critical medicines. The capital will fuel further development, leading to the launch in selected markets in Africa and the Caribbean.